Sales decline 43.72% to Rs 758.30 crore
Net profit of Cadila Healthcare rose 33.20% to Rs 471.40 crore in the quarter ended March 2017 as against Rs 353.90 crore during the previous quarter ended March 2016. Sales declined 43.72% to Rs 758.30 crore in the quarter ended March 2017 as against Rs 1347.30 crore during the previous quarter ended March 2016.For the full year,net profit declined 67.51% to Rs 661.90 crore in the year ended March 2017 as against Rs 2037.50 crore during the previous year ended March 2016. Sales declined 52.52% to Rs 3054.20 crore in the year ended March 2017 as against Rs 6433.20 crore during the previous year ended March 2016.
ParticularsQuarter EndedYear EndedMar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var.Sales758.301347.30 -44 3054.206433.20 -53 OPM %8.0334.16 -10.5140.05 - PBDT469.30512.80 -8 893.102725.00 -67 PBT414.80452.70 -8 642.202503.80 -74 NP471.40353.90 33 661.902037.50 -68
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
